I recall that one of those ex-FDA staffers has expertise in designing preclinical tests, not anything we would hear about. The other didn't have a high profile, either. Kun Jin is at a different level, and it shows.
I believe, however, that those first two probably had a hand in suggesting and effecting Kun Jin's recruitment to Anavex -- which alone would make them good hires.